Chiasma Inc

NASDAQ:CHMA  
4.01
-0.02 (-0.37%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)231.30M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.34 Million
Adjusted EPS-$0.32
See more estimates
10-Day MA$3.84
50-Day MA$3.23
200-Day MA$4.09
See more pivots

Chiasma Inc Stock, NASDAQ:CHMA

140 Kendrick Street, Building C East, Needham, Massachusetts 02494
United States of America
Phone: +1.617.928.5300
Number of Employees: 85

Description

Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Needham, MA.